Abstract
Glycoproteins play important roles in numerous physiological processes and are often implicated in disease. Analysis of site-specific protein glycobiology through glycoproteomics has evolved rapidly in recent years thanks to hardware and software innovations. Particularly, the introduction of parallel accumulation serial fragmentation (PASEF) on hybrid trapped ion mobility time-of-flight mass spectrometry instruments combined deep proteome sequencing with separation of (near-)isobaric precursor ions or converging isotope envelopes through ion mobility separation. However, the reported use of PASEF in integrated glycoproteomics workflows to comprehensively capture the glycoproteome is still limited. To this end, we developed an integrated methodology using timsTOF Pro 2 to enhance N-glycopeptide identifications in complex mixtures. We systematically optimized the ion optics tuning, collision energies, mobility isolation width, and the use of dopant-enriched nitrogen gas (DEN). Thus, we obtained a marked increase in unique glycopeptide identification rates compared to standard proteomics settings, showcasing our results on a large set of glycopeptides. With short liquid chromatography gradients of 30 min, we increased the number of unique N-glycopeptide identifications in human plasma samples from around 100 identifications under standard proteomics conditions to up to 1500 with our optimized glycoproteomics approach, highlighting the need for tailored optimizations to obtain comprehensive data.
Original language | English |
---|---|
Pages (from-to) | 8956-8964 |
Number of pages | 9 |
Journal | Analytical chemistry |
Volume | 96 |
Issue number | 22 |
Early online date | 22 May 2024 |
DOIs | |
Publication status | Published - 4 Jun 2024 |
Bibliographical note
Publisher Copyright:© 2024 The Authors. Published by American Chemical Society
Funding
The collaboration project EnFORCE (Enabling Functional Omics in Routine Clinical Environments, LSHM21032) is cofunded by the PPP Allowance made available by Health\u223CHolland, Top Sector Life Sciences & Health, to stimulate public\u2013private partnerships. This research was financially supported by infrastructure support from the ZonMw Medium Investment Grant 40-00506-98-9001, the Radboud Consortium for Glycoscience, an interfaculty grant from Radboud University, and EUROGLYCAN-omics (ERARE18-117) by ZonMw (90030376501), under the frame of E-Rare-3, the ERA-Net for Research on Rare Diseases and is part of The Netherlands X-omics Initiative, partially funded by NWO (project 184.034.019).
Funders | Funder number |
---|---|
ZonMw Medium Investment | 40-00506-98-9001 |
Radboud Universitair Medisch Centrum | ERARE18-117 |
Radboud Universitair Medisch Centrum | |
ZONMW | 90030376501 |
ZONMW | |
Nederlandse Organisatie voor Wetenschappelijk Onderzoek | 184.034.019 |
Nederlandse Organisatie voor Wetenschappelijk Onderzoek |